C. Ian Mockridge
- Immunology top 2%
- Radiology, Nuclear Medicine and Imaging top 2%
- Genetics top 1%
- Molecular Biology
- Pathology and Forensic Medicine top 2%
- Co-authors
- Freda K. StevensonKathleen N. PotterMark S. CraggGraham PackhamH.T. Claude ChanMartin J. GlennieRuth R. FrenchIsla Wheatley
- Topics
- Monoclonal and Polyclonal Antibodies Research (28 papers)T-cell and B-cell Immunology (19 papers)Chronic Lymphocytic Leukemia Research (14 papers)
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
C. Ian Mockridge
40 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 71
- Immunology 1.3k
- Radiology, Nuclear Medicine and Imaging 874
- Genetics 756
- Molecular Biology 590
- Pathology and Forensic Medicine 530
Countries citing papers authored by C. Ian Mockridge
This map shows the geographic impact of C. Ian Mockridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Ian Mockridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Ian Mockridge more than expected).
Fields of papers citing papers by C. Ian Mockridge
This network shows the impact of papers produced by C. Ian Mockridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Ian Mockridge. The network helps show where C. Ian Mockridge may publish in the future.
Co-authorship network of co-authors of C. Ian Mockridge
This figure shows the co-authorship network connecting the top 25 collaborators of C. Ian Mockridge. A scholar is included among the top collaborators of C. Ian Mockridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Ian Mockridge. C. Ian Mockridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 71 | |
| 3 | 1 | |
| 4 | 16 | |
| 5 | 12 | |
| 6 | 28 | |
| 7 | 35 | |
| 8 | 48 | |
| 9 | 30 | |
| 10 | 43 | |
| 11 | 1 | |
| 12 | 125 | |
| 13 | 174 | |
| 14 | 106 | |
| 15 | 130 | |
| 16 | 30 | |
| 17 | 27 | |
| 18 | 0 | |
| 19 | 17 | |
| 20 | 5 |
About C. Ian Mockridge
C. Ian Mockridge is a scholar working on Immunology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 43 papers that have together received 2.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (28 papers), T-cell and B-cell Immunology (19 papers) and Chronic Lymphocytic Leukemia Research (14 papers). The work is most often cited by research in Genetics (756 citations), Immunology (1.3k citations) and Radiology, Nuclear Medicine and Imaging (874 citations). C. Ian Mockridge has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Freda K. Stevenson, Kathleen N. Potter, Mark S. Cragg, Graham Packham, H.T. Claude Chan, Martin J. Glennie, Ruth R. French, Isla Wheatley, Stephen A. Beers and Ali Roghanian. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.